Skip to main content
. Author manuscript; available in PMC: 2015 May 14.
Published in final edited form as: J Allergy Ther. 2012 Apr 20;3(Suppl 1):S1-007. doi: 10.4172/2155-6121.S1-007

Figure 1.

Figure 1

SM22α-S100A12 transgenic mice have dilated airways (** in A), reduced smooth muscle abundance (arrows in A and B), and impaired response to bronchoconstrictor methacholine at baseline (control) or after allergen sensitization and challenge (OVA) compared to wild type littermate mice (modified from reference 26).